{"id":478760,"date":"2020-04-10T01:10:01","date_gmt":"2020-04-10T01:10:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=478760"},"modified":"2020-04-10T01:10:01","modified_gmt":"2020-04-10T01:10:01","slug":"sepsis-diagnostics-market-to-reach-usd-11-billion-by-2027-key-players-biomrieux-sa-beckman-coulter-inc-becton-dickinson-and-company-sysmex-corporation-and-f-hoffmannla-roche-ag","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/sepsis-diagnostics-market-to-reach-usd-11-billion-by-2027-key-players-biomrieux-sa-beckman-coulter-inc-becton-dickinson-and-company-sysmex-corporation-and-f-hoffmannla-roche-ag_478760.html","title":{"rendered":"Sepsis Diagnostics Market to Reach USD 1.1 Billion by 2027 | Key Players – bioM\u00e9rieux SA; Beckman Coulter, Inc.; Becton, Dickinson and Company; Sysmex Corporation; and F. Hoffmann-La Roche AG"},"content":{"rendered":"
\"Sepsis<\/a><\/p>\n
\n
Grand View Research, Inc. – Market Research And Consulting<\/div>\n<\/div>\n<\/div>\n
According to report published by Grand View Research, The global sepsis diagnostic market size was valued at USD 550.2 million in 2019 and is expected to witness attractive growth over the forecast period<\/div>\n

The global sepsis diagnostic market<\/a> size is expected to reach a value of USD 1.1 billion by 2027, expanding at a CAGR of 9.4%, according to a new report by Grand View Research, Inc. High prevalence of sepsis, introduction of technologically advanced medical examination systems and increasing government initiatives is expected to propel market growth over the forecast period.<\/p>\n

According to CDC estimates, every year more than 1.7 million adults in U.S. suffer from sepsis, which leads to around 270,000 deaths. Furthermore, according to the report published by OECD in 2018, every year around 3.8 million patients suffer from hospital-acquired infections (HAIs) in acute care hospitals in European countries. High prevalence of HAIs in key regions is expected to significantly increase the demand for medical examination solutions, thereby fueling market growth over the forecast period.<\/p>\n

Request a sample Copy of the Global Sepsis Diagnostics Market Research Report @ <\/strong>www.grandviewresearch.com\/industry-analysis\/sepsis-diagnostics-market\/request\/rs1<\/strong><\/a><\/p>\n

Increasing regulatory approval and introduction of technologically advanced medical examination solutions for the life-threatening disease condition are expected to facilitate market growth over the forecast period. In May 2018, T2 Biosystems, Inc., a U.S.-based emerging medical examination solutions company received the U.S. FDA approval for its T2Bacteria Panel, intended for the detection of specific sepsis-causing bacterial pathogens in human whole blood specimens.<\/p>\n

In April 2019, the Scottish Government in collaboration with Sepsis Research (originally called FEAT – The Fiona Elizabeth Agnew Trust) launched a Scotland-wide campaign to spread public awareness about the signs and symptoms of sepsis. Such initiatives to raise public awareness about the disease condition is expected to raise demand for its rapid medical examination solutions and support its market growth in the near future.<\/p>\n

\"U.S.<\/p>\n

Further key findings from the report suggest<\/span>:<\/strong><\/p>\n